(1-1) Formulation And Analytical Development Of New Modalities
(1-2) Excipient And Preservative Issues
(1-3) Polysorbate Issues And New Excipients
(1-4) New Developments In Lyophilization And Alternative Drying Techniques
(1-5) Developability, Robustness, And Scale-Up

Session chair: El Hassane Larhrib, University of Huddersfield, UK

(2-1) Innovative Drug Delivery Technologies
(2-2) Implantable Drug Delivery System
(2-3) Pediatric Drug Delivery systems
(2-4) Routes of Drug Administration

Session chair: Georgina Kate Such, University of Melbourne, Australia

(3-1) Organoleptic and Bulk Characters
(3-2) Solubility analysis
(3-3) Stability analysis

Session chair: Mino R. Caira, University of Cape Town, South Africa

(4-1) Polymers in Drug delivery
(4-2) Smart Materials For Drug Delivery
(4-3) Drug Delivery Vechiles
(4-4) Biomaterials in Drug Delivery

Session chair: Joe E Springer, University of Kentucky, USA

(5-1) Nanoparticles: Innovations And Trends
(5-2) Nanomedicine And Biomedical Applications
(5-3) Nanoparticulate Drug Delivery Systems
(5-4) Nanoparticle Delivery of Non-Coding RNAs
(5-5) Nanoparticle Fabrication
(5-6) Big Data To Help Nanotechnology
(5-7) Clinical Translation Of Nanotechnology
(5-8) Nanoparticles For Immuno-Oncology And Screening

Session chair: Esmaiel Jabbari, University of South Carolina, USA​​​​​​​

(6-1) Future needs for inhaled drug delivery
(6-2) Innovation in nebulized therapy
(6-3) Nebulizers – modern advances
(6-4) Development of propellant-free MDIs
(6-5) Aerosol-mediated delivery of drugs
(6-6) Triple combination inhalers – the challenges
(6-7) Functional respiratory imaging

Session chair: M Teresa Carvajal, Purdue University, USA

(7-1) Controlled Drug Delivery System
(7-2) Ocular Drug Delivery System
(7-3) 2D & 3D Printing in Drug Delivery
(7-4) Drug Delivery: Devices And Equipments

Session chair: Vladimir P. Torchilin, Northeastern University, USA

(8-1) Immunotherapy and Vaccines
(8-2) Novel Vaccine Drug Delivery Systems

Session chair: Georgina Kate Such, University of Melbourne, Australia

Session chair: Robert Walter Makuch, Yale University, USA

(10-1) Peptide Formulation development

Session chair: Vladimir P. Torchilin, Northeastern University, USA

(11-1) Industrial and Physical Pharmacy
(11-2) Pharmaceutical Chemistry
(11-3) Advances in Pharmacological Research
(11-4) Pharmaceutical Organic Chemistry
(11-5) Clinical Research & Clinical Trails in Drug Delivery Systems

Session chair: Robert Houlden, Formulytica Pty. Ltd, Australia

(12-1) Nanoparticle Delivery Across The BBB
(12-2) Brain Penetration And Drug Delivery
(12-3) The Blood-Brain Barrier In States Of Disease
(12-4) Novel Approaches For Bbb Models

Session chairs: Vladimir P. Torchilin, Northeastern University, USA
                                Fabien Gosselet, Artois University, France

(13-1) Controlled environments
(13-2) Antimicrobial activity
(13-3) Microbiology
(13-4) Molecular biology
(13-5) Biochemistry
(13-6) Genetics

(14-1) Neuropharmacology
(14-2) Cardiovascular Pharmacology

Session chair: will be updated soon...

(15-1) Biotherapy Treatment for Cancer
(15-2) Chemotherapy/Biotherapy Patient Education
(15-3) Biological Response Modifiers Used
(15-4) Biotherapy in Wound Treatment
(15-5) Radiopharmaceuticals in nuclear medicine
(15-6) Diagnostic radiopharmaceutical

(16-1) Drug Targeting and Design
(16-2) Targeted Drug Delivery System

Session chair: Ulo Langel, Stockholm University, Sweden

(17-1) Manufacturing equipment and technologies
(17-2) New manufacturing techniques
(17-3) Industrial and Physical Pharmacy
(17-4) Pharmaceutical Technology
(17-5) Pharmaceutical Packaging

Session chair: M Teresa Carvajal, Purdue University, USA

Session chair: Gillian Hutcheon, Liverpool John Moores University, UK

(19-1) In Vitro Models for Drug Screening
​​​​​​​
Session chair: will be updated soon...

(20-1) Quality control and quality assurance
(20-2) Pharmaceutical quality control
(20-3) Scope of Pharmaceutical Analysis and Quality Assurance

Session chair: will be updated soon...

(21-2) Medicinal Chemistry
(21-2) Drug Designing

Session chair: will be updated soon...

(22-1) Regulatory inspections, guidance and technologies
(22-2) GMP, CMC

Session chair: will be updated soon...

(23-1) Genetics & Genetic Engineering
(23-2) Pharmacogenetics and Genomics
(23-3) Drug Metabolism

Session chair: will be updated soon...

Session chair: will be updated soon...